SMPD3

sphingomyelin phosphodiesterase 3

Basic information

Region (hg38): 16:68358327-68448508

Links

ENSG00000103056NCBI:55512OMIM:605777HGNC:14240Uniprot:Q9NY59AlphaFoldGenCCjaxSfariGnomADPubmedClinVar

Phenotypes

GenCC

Source: genCC

No genCC data.

ClinVar

This is a list of variants' phenotypes submitted to ClinVar and linked to the SMPD3 gene.

Variants pathogenicity by type

Statistics on ClinVar variants can assist in determining whether a specific variant type in the SMPD3 gene is commonly pathogenic or not.

In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.

Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.

Variant type Pathogenic Likely pathogenic VUS Likely benign Benign Sum
synonymous
0
missense
46
clinvar
1
clinvar
47
nonsense
0
start loss
0
frameshift
0
inframe indel
0
splice donor/acceptor (+/-2bp)
0
splice region
0
non coding
0
Total 0 0 46 1 0

Variants in SMPD3

This is a list of pathogenic ClinVar variants found in the SMPD3 region.

You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.

Position Type Phenotype Significance ClinVar
16-68361213-T-G not specified Uncertain significance (Oct 12, 2021)2209975
16-68361243-A-G not specified Uncertain significance (Nov 15, 2024)3446435
16-68361271-C-T not specified Uncertain significance (Apr 12, 2024)3321018
16-68361655-C-T not specified Uncertain significance (Apr 15, 2024)3321022
16-68361685-C-T not specified Uncertain significance (Oct 04, 2022)2316054
16-68361686-G-A not specified Uncertain significance (May 21, 2024)3321017
16-68363530-C-T not specified Uncertain significance (Jul 09, 2021)2382861
16-68363539-C-T not specified Uncertain significance (Jan 22, 2024)3166654
16-68363546-G-C not specified Uncertain significance (Nov 24, 2024)3446437
16-68363812-C-T not specified Uncertain significance (Aug 17, 2021)2246459
16-68364819-G-A not specified Uncertain significance (Aug 28, 2023)2621862
16-68364891-C-T not specified Uncertain significance (Sep 22, 2022)2354384
16-68365044-C-T not specified Uncertain significance (Aug 21, 2024)3446428
16-68365056-C-T not specified Uncertain significance (Jan 09, 2024)2353701
16-68365082-C-T not specified Uncertain significance (Jun 04, 2024)3321023
16-68370897-C-T not specified Uncertain significance (Jul 10, 2024)2314011
16-68370902-C-T not specified Uncertain significance (May 22, 2023)2521368
16-68370934-C-T not specified Uncertain significance (Aug 09, 2021)2347702
16-68370995-C-T not specified Uncertain significance (Jan 17, 2024)3166651
16-68371005-C-T not specified Uncertain significance (Sep 04, 2024)2343793
16-68371155-C-T not specified Uncertain significance (Jan 02, 2024)3166650
16-68371166-C-T not specified Uncertain significance (Jan 02, 2024)3166649
16-68371179-C-T not specified Uncertain significance (Jul 20, 2021)2382769
16-68371190-T-C not specified Uncertain significance (Feb 16, 2023)2485679
16-68371194-C-A not specified Uncertain significance (Aug 05, 2024)3446432

GnomAD

Source: gnomAD

GeneTypeBio TypeTranscript Coding Exons Length
SMPD3protein_codingprotein_codingENST00000219334 790361
pLI Probability
LOF Intolerant
pRec Probability
LOF Recessive
Individuals with
no LOFs
Individuals with
Homozygous LOFs
Individuals with
Heterozygous LOFs
Defined p
0.5940.4061257230121257350.0000477
Z-Score Observed Expected Observed/Expected Mutation Rate Total Possible in Transcript
Missense1.113564200.8480.00002824181
Missense in Polyphen96156.710.612611588
Synonymous-1.342282041.120.00001561368
Loss of Function3.66524.60.2030.00000140254

LoF frequencies by population

EthnicitySum of pLOFs p
African & African-American0.0001660.0000905
Ashkenazi Jewish0.0001990.000198
East Asian0.000.00
Finnish0.0001390.000139
European (Non-Finnish)0.00004450.0000440
Middle Eastern0.000.00
South Asian0.000.00
Other0.000.00

dbNSFP

Source: dbNSFP

Function
FUNCTION: Catalyzes the hydrolysis of sphingomyelin to form ceramide and phosphocholine. Ceramide mediates numerous cellular functions, such as apoptosis and growth arrest, and is capable of regulating these 2 cellular events independently. Also hydrolyzes sphingosylphosphocholine. Regulates the cell cycle by acting as a growth suppressor in confluent cells. Probably acts as a regulator of postnatal development and participates in bone and dentin mineralization. {ECO:0000269|PubMed:10823942, ECO:0000269|PubMed:14741383, ECO:0000269|PubMed:15051724}.;
Pathway
Sphingolipid metabolism - Homo sapiens (human);Signal Transduction;Metabolism of lipids;sphingomyelin metabolism/ceramide salvage;Metabolism;Glycosphingolipid metabolism;TNFR1-mediated ceramide production;TNF signaling;Death Receptor Signalling;Glycosphingolipid metabolism;Sphingolipid metabolism;TNFalpha;Ceramide signaling pathway (Consensus)

Recessive Scores

pRec
0.183

Intolerance Scores

loftool
0.152
rvis_EVS
-0.91
rvis_percentile_EVS
10.12

Haploinsufficiency Scores

pHI
0.351
hipred
Y
hipred_score
0.687
ghis
0.555

Essentials

essential_gene_CRISPR
N
essential_gene_CRISPR2
N
essential_gene_gene_trap
N
gene_indispensability_pred
E
gene_indispensability_score
0.984

Gene Damage Prediction

AllRecessiveDominant
MendelianMediumMediumMedium
Primary ImmunodeficiencyMediumMediumMedium
CancerMediumMediumMedium

Mouse Genome Informatics

Gene name
Smpd3
Phenotype
endocrine/exocrine gland phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); limbs/digits/tail phenotype; reproductive system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); respiratory system phenotype; skeleton phenotype;

Gene ontology

Biological process
hematopoietic progenitor cell differentiation;sphingomyelin metabolic process;sphingomyelin catabolic process;cell cycle;peptide hormone secretion;positive regulation of exosomal secretion;positive regulation of ceramide biosynthetic process
Cellular component
Golgi cis cisterna;Golgi membrane;cytoplasm;plasma membrane
Molecular function
sphingomyelin phosphodiesterase activity;protein binding;metal ion binding